OMERS ADMINISTRATION Corp Makes New Investment in Sensus Healthcare, Inc. (NASDAQ:SRTS)

OMERS ADMINISTRATION Corp purchased a new stake in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 55,100 shares of the company’s stock, valued at approximately $381,000. OMERS ADMINISTRATION Corp owned approximately 0.34% of Sensus Healthcare at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in SRTS. IFP Advisors Inc purchased a new stake in shares of Sensus Healthcare during the fourth quarter valued at $95,000. NewEdge Advisors LLC acquired a new stake in Sensus Healthcare during the 4th quarter worth about $109,000. Arrowstreet Capital Limited Partnership grew its stake in Sensus Healthcare by 81.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 150,150 shares of the company’s stock valued at $1,039,000 after purchasing an additional 67,269 shares during the last quarter. JPMorgan Chase & Co. acquired a new position in shares of Sensus Healthcare in the fourth quarter valued at about $27,000. Finally, Virtu Financial LLC acquired a new position in shares of Sensus Healthcare in the fourth quarter valued at about $189,000. Hedge funds and other institutional investors own 25.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on SRTS. HC Wainwright reiterated a “buy” rating and issued a $12.00 target price on shares of Sensus Healthcare in a research report on Friday, April 4th. Lake Street Capital dropped their price objective on shares of Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating on the stock in a report on Tuesday, March 11th. Finally, Maxim Group cut their price objective on shares of Sensus Healthcare from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday.

Sensus Healthcare Stock Up 6.1%

Shares of SRTS opened at $4.73 on Tuesday. Sensus Healthcare, Inc. has a 52 week low of $4.01 and a 52 week high of $9.33. The company has a market capitalization of $78.02 million, a price-to-earnings ratio of 11.83 and a beta of 1.30. The stock’s 50-day moving average price is $4.61 and its 200-day moving average price is $6.10.

Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings results on Thursday, May 15th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.20). The company had revenue of $8.34 million during the quarter, compared to analyst estimates of $7.23 million. Sensus Healthcare had a net margin of 15.90% and a return on equity of 12.60%. As a group, equities analysts anticipate that Sensus Healthcare, Inc. will post 0.32 EPS for the current fiscal year.

Sensus Healthcare Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.